Literature DB >> 19421678

Therapeutic role of oral water soluble iodinated contrast agent in postoperative small bowel obstruction.

P Kumar1, L Kaman, G Singh, R Singh.   

Abstract

INTRODUCTION: Nonoperative measures using an oral water soluble contrast agent is a significant development in the management of patients with postoperative small bowel obstruction.
METHODS: In this prospective randomised trial, patients were randomised into two groups: Group A patients were given an oral water soluble contrast agent and Group B patients were managed conventionally. Surgery was performed as and when indicated. The end-points of the study were to evaluate the time interval between admission and relief of obstruction, the length of hospital stay and the need for surgery.
RESULTS: Of a total of 41 patients, 21 were in Group A and 20 were in Group B. The mean age of Group A patients was 40.48 +/- 14.96 years and it was 43.40 +/- 16.33 years for Group B patients (p-value is 0.553). There were 17 males and four females in Group A, and 14 males and six females in Group B (p-value is 0.441). In Group A, 14 patients had relief of obstruction after administration of the contrast material, and the mean time for relief of obstruction was 7.47 hours. In Group B, 18 patients had relief of obstruction and the time interval was 35.20 hours (p-value is less than 0.001). The mean length of hospital stay was 3.43 +/- 1.08 days for Group A and 5.33 +/- 2.95 days for Group B (p-value is 0.029). Seven patients in Group A and two in Group B were operated on (p-value is 0.071).
CONCLUSION: Administration of an oral water soluble contrast agent in postoperative small bowel obstruction helps in the earlier resolution of the obstruction and decreases the length of hospital stay.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19421678

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  5 in total

1.  Small bowel obstruction-who needs an operation? A multivariate prediction model.

Authors:  Martin D Zielinski; Patrick W Eiken; Michael P Bannon; Stephanie F Heller; Christine M Lohse; Marianne Huebner; Michael G Sarr
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

2.  Therapeutic Role of Water-Soluble Contrast Media in Adhesive Small Bowel Obstruction: a Systematic Review and Meta-Analysis.

Authors:  Amanda Koh; Alfred Adiamah; Abeed Chowdhury; Mohamed Khalid Mohiuddin; Balamurali Bharathan
Journal:  J Gastrointest Surg       Date:  2019-08-13       Impact factor: 3.452

3.  Efficacy of Gastrografin® Compared with Standard Conservative Treatment in Management of Adhesive Small Bowel Obstruction at Mulago National Referral Hospital.

Authors:  Caspar Haule; Peter A Ongom; Timothy Kimuli
Journal:  J Clin Trials       Date:  2013-12-01

4.  Gastrografin reduces the need for additional surgery in postoperative small bowel obstruction patients without long tube insertion: A meta-analysis.

Authors:  Mitsuru Ishizuka; Norisuke Shibuya; Kazutoshi Takagi; Yoshimi Iwasaki; Hiroyuki Hachiya; Taku Aoki; Keiichi Kubota
Journal:  Ann Gastroenterol Surg       Date:  2018-12-17

5.  Water-soluble contrast in the management of adhesive small-bowel obstruction: a Canadian centre's experience with guideline development and implementation.

Authors:  Basheer Elsolh; May-Anh Nguyen; Ferco H Berger; Chirag M Patel; Emily Pearsall; Robin McLeod; Dee Naidu; Ashlie Nadler
Journal:  Can J Surg       Date:  2022-09-14       Impact factor: 2.840

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.